10 Result(s)

Chapter and Conference Paper

High-dose Therapy and Autografting with Mobilized Peripheral Blood Progenitor Cells in Patients with Malignant Lymphoma

In this report we present the data of 100 patients who were autografted with peripheral blood progenitor cells (PBPC) following high-dose conditioning therapy. Fifty-six patients were male and 44 were female w...

R. Haas, H. Goldschmidt, R. Möhle, S. Frühauf, S. Hohaus, B. Witt… in Acute Leukemias V (1996)

Article

Detection of minimal tumor load in blood stem cell autografts in multiple myeloma: Steady-state versus high-dose chemotherapy stem cell mobilization

H. Goldschmidt, M. Moos, F. Cremer… in Journal of Cancer Research and Clinical On… (1995)

Chapter and Conference Paper

Autologous Transplantation with Mafosfamide-Purged Bone Marrow for Acute Myelogenous Leukemia in First and Second Complete Remission

Despite improvements in the conventional treatment of adult patients with acute myelogenous leukemia (AML) the probability of Gontinuous CR ranges from 8% to 45% at 3 years [1]. Intensive consolidation therapy...

R. Haas, R. Ehrhardt, G. Boschmann, B. Witt, H. Döhner, M. Körbling… in Acute Leukemias IV (1994)

Chapter and Conference Paper

Idarubicin/Cytosine Arabinoside and Mitoxantrone/Etoposide with rhGM-CSF Priming for De Novo Acute Myelogenous Leukemia

With conventional induction chemotherapy 60 to 70% of adult patients with acute myelogenous leukemia (AML) achieve complete remission (CR) [1]. Chemotherapeutic protocols for induction treatment mainly consist...

R. Haas, H. Döhner, R. Ehrhardt, H. Goldschmidt, B. Witt, H. Huberts… in Acute Leukemias IV (1994)

Chapter

Mobilization of Blood Stem Cells with Recombinant Human (rh)G-CSF in Patients with Hematological Malignancies and Solid Tumors

Peripheral blood stem cells (PBSC) are being increasingly used for autografting in patients with malignant diseases to circumvent the myelotoxic effects of high-dose therapy [1]. It is generally accepted that ...

R. Haas, S. Hohaus, R. Ehrhardt, H. Goldschmidt… in Peripheral Blood Stem Cell Autografts (1993)

Chapter and Conference Paper

Autologous Bone Marrow Transplantation in Patients with Acute Lymphoblastic Leukemia in Second or Subsequent Complete Remission

With intensive conventional chemotherapy a complete remission (CR) can be achieved in more than 90% of children and 70% of adults with ALL [l].The long-term disease-free survival for patients with ALL depends ...

R. Haas, B. Dörken, E. Ogniben, S. Hohaus, B. Witt, G. Kvalheim… in Acute Leukemias (1992)

Chapter and Conference Paper

Autologous Transplantation of Blood Stem Cells Mobilized with Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Subsequent to Chemotherapy for Relapsed Hodgkin’s Disease

High-dose chemotherapy alone or combined with total body irradiation followed by autologous bone marrow transplantation improves disease-free survival for patients with hematological malignancies and solid tum...

R. Haas, S. Hohaus, A. Schneeweiß… in Cytokines in Hemopoiesis, Oncology, and AI… (1992)

Chapter and Conference Paper

Induction Therapy for Acute Myelogenous Leukemia with Idarubicin/Cytosine Arabinoside and Mitoxantrone/Etoposide in “Response-Adapted” Sequence

With conventional induction chemotherapy 47%–72% of adult patients with acute myelogenous leukemia (AML) achieve complete remission (CR). However, the probability of continuous CR ranges from 8% to 45% at 3 ye...

R. Haas, A. Schneeweiß, B. Brado, B. Witt, W. Hunstein, F. Del Valle… in Acute Leukemias (1992)